Blastomere culture to produce mammalian embryonic stem cells
US8796021B2 · kind B2 · utility
7Cited by
4References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 22, 2008 |
| Grant date | Aug 5, 2014 |
| Priority date | — |
| Expiry date | Jun 4, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2533/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates generally to the field of somatic cell nuclear transfer (SCNT) and to the creation of cloned animals and cells. The disclosure relates to a method of cloning a mammal, obtaining pluripotent cells such as embryonic stem cells, or for reprogramming a mammalian cell using an oocyte and a fertilized embryo.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.